Literature DB >> 22743575

Structural changes of regulatory domain heterodimer of N-methyl-D-aspartate receptor subunits GluN1 and GluN2B through the binding of spermine and ifenprodil.

Hideyuki Tomitori1, Akiko Suganami, Ryotaro Saiki, Satomi Mizuno, Yuki Yoshizawa, Takashi Masuko, Yutaka Tamura, Kazuhiro Nishimura, Toshihiko Toida, Keith Williams, Keiko Kashiwagi, Kazuei Igarashi.   

Abstract

Modeling the binding sites for spermine and ifenprodil on the regulatory (R) domains of the N-methyl-D-aspartate receptor GluN1 and GluN2B subunits was carried out after measuring spermine stimulation and ifenprodil inhibition at receptors containing GluN1 and GluN2B R domain mutants. Models were constructed based on the published crystal structure of the GluN1 and GluN2B R domains, which form a heterodimer (Nature 475:249-253, 2011). The experimental results and modeling suggest that a binding site for spermine was formed by the residues near the cleft between the R1 and R2 lobes of the GluN1 R domain (GluN1R) together with residues on the surface of the R2 (C-terminal side) lobe of the GluN2B R domain (GluN2BR). The ifenprodil binding site included residues on the surface of the R1 lobe (N-terminal side) of GluN1R together with residues near the cleft between the R1 and R2 lobes of GluN2BR. It was confirmed using a Western blot analysis that GluN1R and GluN2BR formed a heterodimer. Models of spermine and ifenprodil binding to the heterodimer were constructed. The modeling suggests that an open space between the two R1 lobes of GluN1R and GluN2BR is promoted through spermine binding and that the R1 lobes of GluN1R and GluN2BR approach each other through ifenprodil binding--an effect opposite to that seen with the binding of spermine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22743575      PMCID: PMC3464035          DOI: 10.1124/jpet.112.192286

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  35 in total

1.  Molecular cloning and characterization of the rat NMDA receptor.

Authors:  K Moriyoshi; M Masu; T Ishii; R Shigemoto; N Mizuno; S Nakanishi
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

2.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

3.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines.

Authors:  Laetitia Mony; Shujia Zhu; Stéphanie Carvalho; Pierre Paoletti
Journal:  EMBO J       Date:  2011-06-17       Impact factor: 11.598

5.  Mechanisms for ligand binding to GluR0 ion channels: crystal structures of the glutamate and serine complexes and a closed apo state.

Authors:  M L Mayer; R Olson; E Gouaux
Journal:  J Mol Biol       Date:  2001-08-24       Impact factor: 5.469

6.  Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors.

Authors:  Florent Perin-Dureau; Julie Rachline; Jacques Neyton; Pierre Paoletti
Journal:  J Neurosci       Date:  2002-07-15       Impact factor: 6.167

7.  Heteromeric NMDA receptors: molecular and functional distinction of subtypes.

Authors:  H Monyer; R Sprengel; R Schoepfer; A Herb; M Higuchi; H Lomeli; N Burnashev; B Sakmann; P H Seeburg
Journal:  Science       Date:  1992-05-22       Impact factor: 47.728

8.  Polyamine transport, accumulation, and release in brain.

Authors:  Takashi Masuko; Kuniko Kusama-Eguchi; Kaori Sakata; Tadashi Kusama; Shigeyuki Chaki; Shigeru Okuyama; Keith Williams; Keiko Kashiwagi; Kazuei Igarashi
Journal:  J Neurochem       Date:  2003-02       Impact factor: 5.372

9.  The phosphorylation of ribosomal protein S6 in rat tissues following cycloheximide injection, in diabetes, and after denervation of diaphragm. A simple immunological determination of the extent of S6 phosphorylation on protein blots.

Authors:  P J Nielsen; K L Manchester; H Towbin; J Gordon; G Thomas
Journal:  J Biol Chem       Date:  1982-10-25       Impact factor: 5.157

10.  Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.

Authors:  Hiroyasu Furukawa; Eric Gouaux
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

View more
  6 in total

1.  Subtype-dependent N-methyl-D-aspartate receptor amino-terminal domain conformations and modulation by spermine.

Authors:  Rita E Sirrieh; David M MacLean; Vasanthi Jayaraman
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

2.  Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.

Authors:  Michael L Berger; Dorota Maciejewska; Jean Jacques Vanden Eynde; Madhusoodanan Mottamal; Jerzy Żabiński; Paweł Kaźmierczak; Mateusz Rezler; Ivana Jarak; Ivo Piantanida; Grace Karminski-Zamola; Annie Mayence; Patrick Rebernik; Arvind Kumar; Mohamed A Ismail; David W Boykin; Tien L Huang
Journal:  Bioorg Med Chem       Date:  2015-06-14       Impact factor: 3.641

Review 3.  Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.

Authors:  Frank S Menniti; Craig W Lindsley; P Jeffrey Conn; Jayvardhan Pandit; Panayiotis Zagouras; Robert A Volkmann
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

4.  A conserved structural mechanism of NMDA receptor inhibition: A comparison of ifenprodil and zinc.

Authors:  Rita E Sirrieh; David M MacLean; Vasanthi Jayaraman
Journal:  J Gen Physiol       Date:  2015-07-13       Impact factor: 4.086

5.  Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors.

Authors:  Flavie Lesept; Arnaud Chevilley; Julie Jezequel; Laurent Ladépêche; Richard Macrez; Margaux Aimable; Sophie Lenoir; Thomas Bertrand; Laëtitia Rubrecht; Pascale Galea; Laurent Lebouvier; Karl-Uwe Petersen; Yannick Hommet; Eric Maubert; Carine Ali; Laurent Groc; Denis Vivien
Journal:  Cell Death Dis       Date:  2016-11-10       Impact factor: 8.469

6.  A Conantokin Peptide Con-T[M8Q] Inhibits Morphine Dependence with High Potency and Low Side Effects.

Authors:  Zhuguo Liu; Zheng Yu; Shuo Yu; Cui Zhu; Mingxin Dong; Wenxiang Mao; Jie Hu; Mary Prorok; Ruibin Su; Qiuyun Dai
Journal:  Mar Drugs       Date:  2021-01-19       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.